4746 — Formosa Laboratories Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapValue Trap

Annual balance sheet for Formosa Laboratories, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,093	1,631	2,510	2,703	2,494
Net Total Accounts Receivable
Net Total Receivables	803	827	1,024	1,258	1,169
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	3,619	4,151	5,244	5,868	5,549
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5,986	5,978	6,095	6,233	6,522
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	12,017	12,751	13,636	13,895	13,833
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2,386	3,142	3,241	2,356	2,900
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	4,622	5,230	6,065	6,211	6,076
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	7,395	7,521	7,571	7,684	7,757
Total Liabilities & Shareholders' Equity	12,017	12,751	13,636	13,895	13,833
Total Common Shares Outstanding